**Core Concept:** Combined oral contraceptive pills (COCPs) are a type of hormonal contraceptive that contains estrogen and progestin hormones, preventing ovulation and thickening cervical mucus to prevent sperm penetration. Postpartum women should avoid COCPs due to potential risks associated with the use of estrogen during lactation.

**Why the Correct Answer is Right:** The correct answer "A. Avoid" is appropriate because in non-breastfeeding women, the administration of combined oral contraceptive pills during the first three weeks postpartum is considered unsafe due to potential risks associated with estrogen exposure during lactation.

Estrogen has a high volume of distribution and can cross the placenta and enter breast milk, potentially leading to adverse effects on the breastfed infant, including jaundice, lethargy, and decreased feeding. Moreover, estrogen exposure can interfere with lactation, making it challenging for the mother to produce and maintain sufficient milk supply.

**Why Each Wrong Option is Incorrect:**

**Option B. Contraindicated:** While the use of COCPs is contraindicated during the first three weeks postpartum, the correct answer "A. Avoid" is more appropriate as it emphasizes the precautions rather than merely listing the contraindications.

**Option C. Safe:** The use of COCPs is not safe during the first three weeks postpartum due to the risks associated with estrogen exposure during lactation.

**Option D. Indicated:** This option contradicts the known risks associated with estrogen exposure during lactation, making it incorrect.

**Clinical Pearl:** To ensure optimal breastfeeding success and infant wellbeing, women should avoid using combined oral contraceptive pills during the first three weeks postpartum. Encouraging breastfeeding and using alternative contraceptive methods, such as copper intrauterine devices (IUDs) or barrier methods, would be recommended during this period.